Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P MALEK

Showing results (151-160 of 185) with videos related to

Pageof 19
Sort By:
Thrombosis and Haemostasis|February 26, 2021
Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19Stefanie Hammer, Helene Häberle, Christian Schlensak, et al.
Cancer Cell|June 4, 2013
A critical role for notch signaling in the formation of cholangiocellular carcinomasSteffen Zender, Irina Nickeleit, Torsten Wuestefeld, et al.
Cancer Cell|July 5, 2008
Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibitionIrina Nickeleit, Steffen Zender, Florenz Sasse, et al.
Frontiers in Oncology|April 12, 2024
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusionChristopher Hackenbruch, Jens Bauer, Jonas S Heitmann, et al.
JCO Precision Oncology|September 14, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment OptionsMichael Bitzer, Leonie Ostermann, Marius Horger, et al.
Frontiers in Immunology|August 14, 2018
β-Defensin 1 Is Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids <i>via</i> Farnesoid X Receptor and Constitutive Androstane ReceptorThomas Klag, Maria Thomas, Dirk Ehmann, et al.
Cancers|December 23, 2020
Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular CarcinomaStephan Spahn, Daniel Roessler, Radu Pompilia, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2006
Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancerInke Timmerbeul, Carrie M Garrett-Engele, Uta Kossatz, et al.
Experimental Cell Research|January 26, 2018
Silencing of Kangai 1 C-terminal interacting tetraspanin suppresses progression of cholangiocarcinomaKhac Cuong Bui, Samarpita Barat, Xi Chen, et al.
European Journal of Pediatrics|December 14, 2025
Endoscopic retrograde cholangiopancreatography as a diagnostic key tool for biliary atresia: feasibility, safety and accuracy in neonates with cholestatic liver diseaseSteffen Hartleif, Michael Esser, Jörg Fuchs, et al.
Pageof 19

Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Thrombosis and Haemostasis|February 26, 2021
Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19Stefanie Hammer, Helene Häberle, Christian Schlensak, et al.
Cancer Cell|June 4, 2013
A critical role for notch signaling in the formation of cholangiocellular carcinomasSteffen Zender, Irina Nickeleit, Torsten Wuestefeld, et al.
Cancer Cell|July 5, 2008
Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibitionIrina Nickeleit, Steffen Zender, Florenz Sasse, et al.
Frontiers in Oncology|April 12, 2024
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusionChristopher Hackenbruch, Jens Bauer, Jonas S Heitmann, et al.
JCO Precision Oncology|September 14, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment OptionsMichael Bitzer, Leonie Ostermann, Marius Horger, et al.
Frontiers in Immunology|August 14, 2018
β-Defensin 1 Is Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids <i>via</i> Farnesoid X Receptor and Constitutive Androstane ReceptorThomas Klag, Maria Thomas, Dirk Ehmann, et al.
Cancers|December 23, 2020
Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular CarcinomaStephan Spahn, Daniel Roessler, Radu Pompilia, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2006
Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancerInke Timmerbeul, Carrie M Garrett-Engele, Uta Kossatz, et al.
Experimental Cell Research|January 26, 2018
Silencing of Kangai 1 C-terminal interacting tetraspanin suppresses progression of cholangiocarcinomaKhac Cuong Bui, Samarpita Barat, Xi Chen, et al.
European Journal of Pediatrics|December 14, 2025
Endoscopic retrograde cholangiopancreatography as a diagnostic key tool for biliary atresia: feasibility, safety and accuracy in neonates with cholestatic liver diseaseSteffen Hartleif, Michael Esser, Jörg Fuchs, et al.
Pageof 19